Overview
- 18 inspections across 18 sites are on record.
- 43 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-30.
At a glance
Inspections
18
Sites
18
Observations
43
Career since
Mar 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Amneal Pharmaceuticals, LLC | 30 Apr 2026 | Human Drugs | |
| Sunrise Pharmaceutical, Inc. | 31 Mar 2026 | Human Drugs | On file |
| Miyoshi America, Inc | 6 Feb 2026 | Human Drugs | On file |
| Guardian Drug Co. Inc. | 16 Jan 2026 | Human Drugs | |
| Unipharm Inc. | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Amneal Pharmaceuticals, LLCPiscataway, United States1 insp.
Sunrise Pharmaceutical, Inc.Rahway, United States1 insp.
Miyoshi America, IncDayville, United States1 insp.
Guardian Drug Co. Inc.Dayton, United States1 insp.
Unipharm Inc.Waterbury, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Gam S Zamil2 shared
Anthony J Donato2 shared
Syeda N Mahazabin2 shared
Young K Chou1 shared
Luxuly Abraham1 shared
Samir C Gala1 shared
Tomika L Crafter1 shared
Janet A Rajan1 shared
Tamil Arasu1 shared
JoshRenzo N Ramilo1 shared
Full investigator report
Get the verbatim findings behind Alisha B Patel's 43 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site